CAMP cGMP PDE NO

Aus coViki
Wechseln zu: Navigation, Suche

Nitric oxide

  • GET 2020. Targeting the NO-cGMP-PDE5 pathway in COVID-19 infection. Extract
  • GET ä. Could nasal nitric oxide help to mitigate the severity of COVID-19? Extract
  • GET 2020. Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome. Extract
  • GET 2020. Potential Immunoregulatory and Antiviral/SARS-CoV-2 Activities of Nitric Oxide. Extract
  • GET 2020. Treatment of COVID-19 by Inhaled NO to Reduce Shunt? Extract
  • GET 2020. Nitric oxide dosed in short bursts at high concentrations may protect against Covid 19. Extract
  • GET 2020. Inhaled nitric oxide treatment in spontaneously breathing COVID-19 patients. Extract


PDE4 Inhibitors

  • GET 2020. Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19. Extract
  • GET 2020. Letter to the editor: Immunomodulation by phsphodiesterase-4 inhibitor in COVID-19 patients. Extract
  • GET 2020. Rationale for Evaluating PDE4 Inhibition for Mitigating against Severe Inflammation in COVID-19 Pneumonia and Beyond. Extract


PDE5 Inhibitors

  • GET 2020. Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology Extract
  • GET ä. Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19) Extract
  • GET 2020. Phosphodiesterase Type 5 Inhibitors and COVID-19: Are They Useful In Disease Management? Extract
Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge